oral contraceptive pills
Phase 3Small molecule
oral contraceptive pills is one of 48 small molecule programs targeting Amenorrhea. It is currently in Phase 3.
2
Indications
6
Total Trials
1
Active Trials
47
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
175 competitors in Polycystic Ovary Syndrome
#DrugCompanyPhaseTrials
1Farxiga
AstraZenecaPhase 3
Decadron
AAspen Global Incorporated
Phase 3
Glucophage
Boehringer IngelheimPhase 3
oral contraceptive pills
SSheba Medical Center
Phase 3
Clomid
FerringPreclinical
Precose
BayerPreclinical
Proglycem
TevaPreclinical
Clomid
EMD SeronoPreclinical
Cetrotide
EMD SeronoPreclinical
Lipitor
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Ovulation Induction1 trial
Optimizing Ovulation Induction in the Poor Responder
Withdrawn·—·N/A·NCT01200537
Amenorrhea1 trial
Study of Leptin for the Treatment of Hypothalamic Amenorrhea
Completed·—·Phase 2·NCT00130117·20 enrolled
1 more indication
Tranexamic Acid1 trial
Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study
Completed·—·N/A·NCT01428713·17 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for oral contraceptive pills. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- SSheba Medical Center